A Virginia House committee on Tuesday advanced a bipartisan proposal to create a Prescription Drug Affordability Board, ...

From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 ...

The Wholesale Prescription Drug Importation Program Act calls for the Illinois Department of Public Health to establish a ...

The high cost of living is a continuing burden for working families in Pueblo and across Colorado. A federal program intended ...

Pharmacy professor Nicole Albanese discusses the science behind drugs like Ozempic and Wegovy, their potential to treat other ...

The Baltimore City Board of School Commissioners is suing Eli Lilly and Co., UnitedHealth Group, CVS and several other drug ...

January is a big time for drugmakers to hike prices. This year saw higher prices for 575 medications so far, including ...

The U.S. Federal Trade Commission on Tuesday published the second part of its investigation into how prescription drug ...

A report from the Federal Trade Commission (FTC) has determined that pharmacy benefit managers (PBMs) are linked to significant cost increases for cancer, HIV, and other critical specialty drugs.

The Federal Trade Commission said in its second interim staff report on prescription-drug middlemen that the "significant markups" in prices above what the drugs cost generated an extra $7.3 billion ...

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic drugs ...

The DEA is proposing a special registration process for remote prescribing of controlled substances such as Xanax, Vicodin ...